Position in NBIX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$762,643
+$108,554 QoQ
Shares Held
4,525
-8.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#430
of 768 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WADDELL & ASSOCIATES, LLC holds $1,250,290 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (61.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
4,525 | $762,643 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
900 | $487,647 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $762,643 | 4,525 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $654,089 | 4,965 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $460,238 | 3,245 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $311,783 | 2,221 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||